Mutant huntingtin (mHTT) forms protein aggregates characteristic of Huntington’s Disease pathology.
In this publication, we focus on:
- a background to Huntington’s Disease including the mutant huntingtin gene (mHTT)
- a discussion of the benefits of sensitive biomarkers to monitor disease progression
- the discovery of an mHTT aggregate-specific PET ligand suitable for live brain imaging